HOME
  LIPASE
  PPI
  HIV
  VACCINES
  AFP
  CHOLERA
  FUSION
  GENOMES
  CONTACT US

HIV/AIDS vaccine

1. P. Shapshak, P. Kangueane, R.K. Fujimura, D. Commins, F. Chiappelli, E. Singer, A. Levine, A. Minagar, F.J. Novembre, C. Somboonwit, A. Nath, J. Sinnott, Editorial NeuroAIDS Review November (2010) AIDS, 14;25(2): 123-141. [PubMed]  




2. Shapshak P , Duncan R , Nath A, Turchan J , Kangueane P, Shapshak SAM, Rodriguez H, Duran EM, Ziegler F, Amaro E, Lewis A, Rodriguez A, Minagar A, Davis W, Seth R, Chiappelli F, and Kazic T. Gene Chromosomal Organization and Expression in Cultured Human Neurons Exposed to Cocaine and HIV-1 proteins gp120 and tat: Drug Abuse and NeuroAIDS. FRONTIERS IN BIOSCIENCE, 11, 1774-1793, May 1, 2006. [PubMed]  




3. Shapshak P, Duncan R, Turchan J, Nath A, Minagar A, Kangueane P, Davis W, Chiappelli F, Elkomy F., Seth R, and Kazic T. Bioinformatics models in drug abuse and Neuro-AIDS: Using and developing databases. BIOINFORMATION, 1(3): 86-88, 2006. [PubMed]  




4. Kangueane P, R. Kayathri, M. Kishore Sakharkar, D. R. Flower, K. Sadler, F. Chiappelli, D. M. Segal, and P. Shapshak. Designing HIV gp120 peptide vaccines: rhetoric or reality for neuroAIDS, Chapter 9. In K. Goodkin, P. Shapshak, and A. Verma (ed.), The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment. ISBN: 9781555813697; ISBN10: 1555813690, ASM Press, Washington, DC, 105 – 119, (2008)  




5. Shapshak, P., A. Minagar, P. Kangueane, S. Frost, S. L. Kosakovsky Pond, S. Zarate, E. Singer, D. Commins, A. De Groot, M. Quinones-Mateu, and E. Terwilliger. The role of viral genetic variability in HIV-1-associated neurocognitive disorders, Chapter 15. In K. Goodkin, P. Shapshak, and A. Verma (ed.), The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment. ISBN: 9781555813697; ISBN10: 1555813690, ASM Press, Washington, DC, 199-216 (2008)